Profilo
Boris Minev formerly worked at Genelux Corp., as Director-Immunotherapy &Translational Oncology from 2010 to 2015, UCSD Moores Cancer Center, as Director-Tumor Immunology & Immunotherap from 2000 to 2015, and Calidi Biotherapeutics, Inc., as Chief Medical Officer & President-Medical Affairs from 2015 to 2025.
Dr. Minev received his doctorate degree from Medical University Sofia.
Precedenti posizioni note di Boris Minev
| Società | Posizione | Fine |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 29/07/2025 |
| GENELUX CORPORATION | Corporate Officer/Principal | 01/06/2015 |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical research services for cancer treatment | Corporate Officer/Principal | 01/06/2015 |
Formazione di Boris Minev
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical research services for cancer treatment | Commercial Services |
Medical University Sofia
Medical University Sofia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
















